Cargando…

A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers

Alzheimer’s disease (AD) is a progressive and fatal neurodegenerative disease, with no effective treatment or cure. A gold standard therapy would be treatment to slow or halt disease progression; however, knowledge of causation in the early stages of AD is very limited. In order to determine effecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawrence, Emma, Vegvari, Carolin, Ower, Alison, Hadjichrysanthou, Christoforos, De Wolf, Frank, Anderson, Roy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611893/ https://www.ncbi.nlm.nih.gov/pubmed/28759968 http://dx.doi.org/10.3233/JAD-170261

Ejemplares similares

The development of a stochastic mathematical model of Alzheimer’s disease to help improve the design of clinical trials of potential treatments
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2018)

How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?
por: Vegvari, Carolin, et al.
Publicado: (2016)

Understanding the within-host dynamics of influenza A virus: from theory to clinical implications
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2016)

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease
por: Ower, Alison K., et al.
Publicado: (2017)

Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections
por: Vegvari, Carolin, et al.
Publicado: (2016)

The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2020)

Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2018)

The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment?
por: Evans, Stephanie, et al.
Publicado: (2018)

Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets
por: Evans, Stephanie, et al.
Publicado: (2019)

Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology
por: Thomas, David X., et al.
Publicado: (2020)

Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
por: Stylianou, Andria, et al.
Publicado: (2017)

Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2022)

SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies
por: Beukenhorst, Anna L., et al.
Publicado: (2023)

Models of kleptoparasitism on networks: the effect of population structure on food stealing behaviour
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2017)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

Combining hippocampal volume metrics to better understand Alzheimer’s disease progression in at-risk individuals
por: McRae-McKee, K., et al.
Publicado: (2019)

SARS‐CoV‐2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy
por: Zhang, Shengyuan, et al.
Publicado: (2023)

Human population movement can impede the elimination of soil-transmitted helminth transmission in regions with heterogeneity in mass drug administration coverage and transmission potential between villages: a metapopulation analysis
por: Vegvari, Carolin, et al.
Publicado: (2019)

Soil-transmitted helminths and schistosome infections in Ethiopia: a systematic review of progress in their control over the past 20 years
por: Maddren, Rosie, et al.
Publicado: (2021)

Correction: Soil-transmitted helminths and schistosome infections in Ethiopia: a systematic review of progress in their control over the past 20 years
por: Maddren, Rosie, et al.
Publicado: (2023)

The ‘breakpoint’ of soil-transmitted helminths with infected human migration
por: Hardwick, Robert J., et al.
Publicado: (2020)

COVID-19 spread in the UK: the end of the beginning?
por: Anderson, Roy M, et al.
Publicado: (2020)

Spatial scales in human movement between reservoirs of infection
por: Hardwick, Robert J., et al.
Publicado: (2021)

The measurement of air flow
por: Ower, E, et al.
Publicado: (1977)

Endotyping of Cholesteatoma: Which Molecular Biomarkers? A Systematic Review
por: Cantone, Elena, et al.
Publicado: (2022)

Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium
por: Chibnik, Lori B., et al.
Publicado: (2017)

Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
por: Buchhave, Peder, et al.
Publicado: (2009)

Impact of Key Assumptions About the Population Biology of Soil-Transmitted Helminths on the Sustainable Control of Morbidity
por: Vegvari, Carolin, et al.
Publicado: (2021)

High Selection Pressure Promotes Increase in Cumulative Adaptive Culture
por: Vegvari, Carolin, et al.
Publicado: (2014)

The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome
por: Anderson, Roy M., et al.
Publicado: (2021)

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
por: Stomrud, Erik, et al.
Publicado: (2015)

Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
por: Swarbrick, S., et al.
Publicado: (2019)

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review
por: Gleerup, Helena Sophia, et al.
Publicado: (2019)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
por: Tan, Meng-Shan, et al.
Publicado: (2020)

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
por: Contador, José, et al.
Publicado: (2021)

Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease
por: Lin, Rong-Rong, et al.
Publicado: (2021)

Which Actigraphy Dimensions Predict Longitudinal Outcomes in Bipolar Disorders?
por: Ferrand, Lisa, et al.
Publicado: (2022)

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease
por: Huang, Meiyan, et al.
Publicado: (2017)

A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
por: McGhee, David J. M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8u2647n0moisusbr0es3o2iu7t